# Contrast Enhanced Ultrasound Medical Imaging for Identifying Breast Masses

> **NCT06171607** · PHASE1 · RECRUITING · sponsor: **University of Southern California** · enrollment: 100 (estimated)

## Conditions studied

- Breast Carcinoma

## Interventions

- **PROCEDURE:** Contrast-Enhanced Ultrasound
- **DRUG:** Perflutren Lipid Microspheres
- **DRUG:** Sulfur Hexafluoride Lipid Microspheres

## Key facts

- **NCT ID:** NCT06171607
- **Lead sponsor:** University of Southern California
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-11-05
- **Primary completion:** 2026-11-05
- **Final completion:** 2027-11-05
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-02-02

## Collaborators

- National Cancer Institute (NCI)

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06171607

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06171607, "Contrast Enhanced Ultrasound Medical Imaging for Identifying Breast Masses". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT06171607. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*